REWRITE-CAD Protocol: Risk Evaluation With AI-CPA to Reduce Progression and Improve Lifetime Care for Patients With Known Coronary Artery Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 350 participants.
Also called NCT07834372
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 350 participants
- Sponsor
- Registry
-
NCT07834372
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07834372. Randomized; no masking; primary purpose prevention. Start 2026-10 (anticipated); primary completion 2027-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- REWRITE-CAD Protocol: Risk Evaluation With AI-CPA to Reduce Progression and Improve Lifetime Care for Patients With Known Coronary Artery Disease
- Acronym
- REWRITE-CAD
- Intervention (Device)
- Heartflow Analysis
- Lead sponsor
- HeartFlow, Inc.
- Collaborator
- Avania
Record details
- Record id
cardio:ct-nct07834372- Content hash
ce4f77cf56b6c531678bf23bc037a77e32735ebdaa3618484927b731d4e671b8